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Background:  Calcification of the aortic valve and adjacent structures is associated with increased morbidity and mortality. 
Histopathological data support a pathogenetic role for inflammatory, lipid, and mineral metabolism pathways, but the correlations of plasma 
biomarkers are not well defined.
methods:  We evaluated in a population-based study of older adults several candidate biomarkers that have been implicated in the 
pathology of valvular/annular calcification, but whose associations with specific types of calcification have not been investigated fully or at 
all. Of various plasma biomarkers available, we selected analytes reflecting lipid (lipoprotein [Lp] (a), lipoprotein-associated phospholipase 
A2 [LpPLA2] mass and activity), inflammation (interleukin-6, soluble [s] CD14), and mineral metabolism (fetuin-A, fibroblast growth factor 
[FGF]-23) pathways that were measured within 5 years of the 1994-95 echocardiograms. Relations with aortic valve calcium (AVC), aortic 
annular calcium and mitral annular calcium (MAC) were assessed with relative risk regression.
results:  Of 3809 subjects with available Echo measures (age 72±5, 60% women), most had available biomarker measures. Calcification 
was prevalent: 41% had MAC, 45% aortic annular, and 59% AVC. After adjustment (age, sex, race, education, body mass index, systolic 
blood pressure, antihypertensives, diabetes, smoking, renal function, cardiovascular disease, lipids, C-reactive protein), Lp(a), LpPLA2 
mass and activity, and sCD14 were significantly associated with AVC. RRs for AVC per SD increment (95% confidence interval) were: 
Lp(a), 1.05 (1.02-1.08); LpPLA2 mass, 1.04 (1.01-1.07) and activity, 1.04 (1.00-1.07); sCD14, 1.04 (1.01-1.07). FGF-23 was significantly 
associated with MAC (1.09 [1.02-1.17]).
conclusion:  This study demonstrates novel associations of plasma FGF-23 with MAC, and LpPLA2 and sCD14 with AVC, extending 
that previously reported for Lp(a). These findings are consistent with the proposed roles of oxidized lipid, macrophage, and phosphate 
regulation in valvular mineralization. Further study of these pathways may be fruitful for prevention of calcification and its complications.
